GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 15, 2019

Total Value: $791M (100.0% shares, 0.0% debt)

Holdings (40)

BCRX BIOCRYST PHARMACEUTICALS 7.8%
Value $61.51M Shares 7,622,256 Est. Cost $5.12 Unrealized +51.9%
IOVA IOVANCE BIOTHERAPEUTICS INC 6.2%
Value $49.27M Shares 5,567,348 Est. Cost $9.91 Unrealized -2.7%
GLOBAL BLOOD THERAPEUTICS INC 6.1%
Value $48.44M Shares 1,180,000 Est. Cost $41.05 Unrealized
ACCELERON PHARMA INC 5.7%
Value $45.14M Shares 1,036,575 Est. Cost $10938.26 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.6%
Value $44.5M Shares 2,752,256 Est. Cost $18.73 Unrealized +3.7%
PTCT PTC THERAPEUTICS INC 5.3%
Value $42.04M Shares 1,225,000 Est. Cost $24.56 Unrealized +46.4%
KURA KURA ONCOLOGY INC 4.9%
Value $38.88M Shares 2,769,527 Est. Cost $12.07 Unrealized +9.8%
UTHR UNITED THERAPEUTICS CORP DEL 4.8%
Value $38.2M Shares 350,800 Est. Cost $115.91 Unrealized +0.0%
ZOGENIX INC 4.6%
Value $36.46M Shares 1,000,000 Est. Cost $36.46 Unrealized
AUDENTES THERAPEUTICS INC 4.5%
Value $35.35M Shares 1,657,873 Est. Cost $21.32 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 4.2%
Value $33.14M Shares 200,000 Est. Cost Unrealized
PBYI PUMA BIOTECHNOLOGY INC 3.5%
Value $28.08M Shares 1,379,700 Est. Cost $30.01 Unrealized 0.0%
ARRAY BIOPHARMA INC 3.3%
Value $26.36M Shares 1,850,000 Est. Cost $14.25 Unrealized
SPARK THERAPEUTICS INC 3.1%
Value $24.68M Shares 630,600 Est. Cost $10538.47 Unrealized
FIVE PRIME THERAPEUTICS INC 2.8%
Value $22.3M Shares 2,398,409 Est. Cost $6226.03 Unrealized
INTERCEPT PHARMACEUTICALS INC 2.5%
Value $20.16M Shares 200,000 Est. Cost Unrealized
CYTK CYTOKINETICS INC 2.5%
Value $20.05M Shares 3,173,288 Est. Cost $7.94 Unrealized -7.7%
ZAFGEN INC 2.3%
Value $17.81M Shares 3,598,392 Est. Cost $9.93 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.8%
Value $14.53M Shares 4,047,561 Est. Cost $7.50 Unrealized
SVRA SAVARA INC CMN 1.7%
Value $13.77M Shares 1,819,195 Est. Cost $11.29 Unrealized -20.3%
TGTX TG THERAPEUTICS INC 1.6%
Value $12.3M Shares 3,000,000 Est. Cost $9.17 Unrealized -45.8%
RVLPQ OSMOTICA PHARMACEUTICALS PLC 1.5%
Value $11.63M Shares 1,500,000 Est. Cost $8.00 Unrealized 0.0%
CYMABAY THERAPEUTICS INC 1.4%
Value $11.16M Shares 1,418,489 Est. Cost $7.87 Unrealized
MILLENDO THERAPEUTICS INC 1.3%
Value $10.24M Shares 1,288,093 Est. Cost $7.95 Unrealized
KRYS KRYSTAL BIOTECH INC 1.3%
Value $10.23M Shares 492,100 Est. Cost $20.94 Unrealized 0.0%
ENTA ENANTA PHARMACEUTICALS INC 1.3%
Value $10.16M Shares 143,481 Est. Cost $100.17 Unrealized -23.5%
AMAG PHARMACEUTICALS INC 1.3%
Value $10.1M Shares 664,681 Est. Cost $15.19 Unrealized
PROTEOSTASIS THERAPEUTICS INC 1.2%
Value $9.867M Shares 3,045,423 Est. Cost $3.24 Unrealized
MENLO THERAPEUTICS INC 1.1%
Value $9.082M Shares 2,204,407 Est. Cost $7.51 Unrealized
NOVAVAX INC 1.0%
Value $8.28M Shares 4,500,000 Est. Cost Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value $6.431M Shares 955,618 Est. Cost $7.68 Unrealized +3.3%
INTRA CELLULAR THERAPIES INC 0.6%
Value $4.556M Shares 400,000 Est. Cost Unrealized
VYGR VOYAGER THERAPEUTICS INC 0.4%
Value $3.432M Shares 365,132 Est. Cost $19.24 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 0.4%
Value $3.1M Shares 27,500 Est. Cost $250.94 Unrealized -38.3%
ALNY ALNYLAM PHARMACEUTICALS INC 0.4%
Value $2.931M Shares 40,197 Est. Cost $99.37 Unrealized -22.6%
SAGE THERAPEUTICS INC 0.3%
Value $2.491M Shares 26,000 Est. Cost Unrealized
SAGE THERAPEUTICS INC 0.3%
Value $2.491M Shares 26,000 Est. Cost Unrealized
ARGX ARGENX SE 0.2%
Value $1.777M Shares 18,500 Est. Cost $75.84 Unrealized
SUNESIS PHARMACEUTICALS INC 0.0%
Value $132K Shares 317,962 Est. Cost $2.00 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.0%
Value $105K Shares 130,137 Est. Cost $6.45 Unrealized